- Home
- EXOZ
EXOZ
EXOZYMES INC
as 04-21-2025 4:00pm EST
Stocks
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 138.0M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 8.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.50 - $23.99 | Next Earning Date: | 05-15-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest EXOZYMES INC News
EXOZ Breaking Stock News: Dive into EXOZ Ticker-Specific Updates for Smart Investing
ACCESS Newswire
7 days ago
New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI Founder & CEO Dan O'Toole (ARAI)
GlobeNewswire
11 days ago
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant
GlobeNewswire
19 days ago
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
GlobeNewswire
19 days ago
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
GlobeNewswire
a month ago
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
ACCESS Newswire
2 months ago
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce
GlobeNewswire
2 months ago
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.
GlobeNewswire
2 months ago
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
Compare EXOZ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EXOZ EXOZYMES INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.